New International Guidelines for Chronic Obstructive Pulmonary Disease

Pauwels RA , Buist AS , Calverley PMA , Jenkins CR , Hurd SS , on behalf of the GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). Executive Summary. Respir Care 2001;46(8):798–825.

American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152(5 Pt 2):S77–S121.

Jones PW , Bosh TK . Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997;155(4):1283–1289.

Calverley PM . Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease (editorial). Am J Respir Crit Care Med 2000;161(2 Pt 1):341–342; discussion, 344.

Barnes PJ . Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease (editorial). Am J Respir Crit Care Med 2000;161(2 Pt 1):342–344; discussion, 344.

Burge PS , Calverley PM , Jones PW , Spencer S , Anderson JA , Maslen TK . Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000;320(7245):1297–1303.

Senderovitz T , Vestbo J , Frandsen J , Maltbaek N , Norgaard M , Nielsen C , Kampmann JP . Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine. Respir Med 1999;93(10):715–718.

Vestbo J , Sorensen T , Lange P , Brix A , Torre P , Viskum K. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999;353(9167):1819–1823.

Pauwels RA , Lofdahl CG , Laitinen LA , Schouten JP , Postma DS , Pride NB , Ohlsson SV . Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999;340(25):1948–1953.

Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000;343(26):1902–1909.

Jones PW , Quirk FH , Baveystock CM , Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145(6):1321–1327.

Jones PW , Quirk FH , Baveystock CM . The St George's Respiratory Questionnaire. Respir Med 1991;85(Suppl B):25–31; discussion 33–37.

Curtis JR . Communicating with patients and their families about advance care planning and end-of-life care. Respir Care 2000;45(11):1385–1394; discussion 1394–1398.

Luce JM , Luce JA . Perspectives on care at the close of life. Management of dyspnea in patients with far-advanced lung disease: "Once I lose it, it's kind of hard to catch it...". JAMA 2001;285(10):1331–1337.

State-of-the-Art Conference on Palliative Respiratory Care. Respir Care 2000;45(11,12):1318–1410, 1460–1540.